This inventor holds 1 USPTO granted patent. Top assignee: Astra Aktiebolag. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Eva C Mellin: Innovator in CNS Treatment
Introduction
Eva C Mellin is a prominent inventor based in Uppsala, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system (CNS) disorders. Her innovative work has led to the development of a unique compound that holds promise for various therapeutic applications.
Latest Patents
Eva C Mellin holds a patent for a compound known as 8-substituted-2-aminotetralins. This compound is characterized by a specific formula where Z can be hydrogen or halogen, and Q can be COR¹ or a 5- or 6-membered aryl. The compound has various substituents and configurations, making it versatile for pharmaceutical preparations. The patent also covers processes for the preparation of these compounds, their use in treating CNS disorders, and the enantiomers and salts derived from them. She has 1 patent to her name.
Career Highlights
Eva has built her career at Astra Aktiebolag, a leading pharmaceutical company. Her work focuses on the development of innovative treatments that address complex health issues. Her dedication to research and development has positioned her as a key figure in her field.
Collaborations
Eva has collaborated with notable colleagues, including Hong Yu and Sven-Erik Hillver. These partnerships have enhanced her research efforts and contributed to the advancement of her projects.
Conclusion
Eva C Mellin is a trailblazer in the pharmaceutical industry, with her innovative compounds paving the way for new treatments in CNS disorders. Her contributions continue to impact the field positively.